Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Pain × Modafinil × Clear all

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Fatigue 5 Neoplasms 2 Sleep Wake Disorders 1 Pain 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Glioma 1 Central Nervous System Neoplasms 1 Brain Neoplasms 1

Interventions

Morphine 6 Methadone 4 Fentanyl 4 Zoledronic Acid 3 Tapentadol 2 Ropivacaine 2 Radiotherapy 2 Pregabalin 2 Prednisone 2 Ketamine 2 Ibandronic Acid 2 Hydromorphone 2 Glutamine 2 Acupuncture Therapy 2 pegfilgrastim 1 oxycodone naloxone combination 1 naloxegol 1 ixabepilone 1 incobotulinumtoxinA 1 imisopasem manganese 1 cyclobenzaprine 1 cabozantinib 1 acetaminophen, aspirin, caffeine drug combination 1 Zolpidem 1 Surveys and Questionnaires 1 Sugars 1 Standard of Care 1 Soybean Proteins 1 Sodium Bicarbonate 1 Oxycodone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00267332 2018-05-07

Modafinil in Opioid Induced Sedation

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 3 Terminated

Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡